As of 2025-08-12, the Intrinsic Value of Target Healthcare REIT PLC (THRL.L) is 128.11 GBP. This THRL.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 100.60 GBP, the upside of Target Healthcare REIT PLC is 27.30%.
The range of the Intrinsic Value is 100.91 - 170.70 GBP
Based on its market price of 100.60 GBP and our intrinsic valuation, Target Healthcare REIT PLC (THRL.L) is undervalued by 27.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 100.91 - 170.70 | 128.11 | 27.3% |
| DCF (Growth 10y) | 117.90 - 191.04 | 146.53 | 45.7% |
| DCF (EBITDA 5y) | 83.04 - 117.47 | 99.04 | -1.6% |
| DCF (EBITDA 10y) | 103.82 - 144.76 | 122.47 | 21.7% |
| Fair Value | 293.02 - 293.02 | 293.02 | 191.27% |
| P/E | 159.64 - 270.26 | 204.43 | 103.2% |
| EV/EBITDA | 65.74 - 149.33 | 108.07 | 7.4% |
| EPV | 72.52 - 102.93 | 87.73 | -12.8% |
| DDM - Stable | 89.05 - 173.78 | 131.42 | 30.6% |
| DDM - Multi | 120.25 - 179.73 | 143.89 | 43.0% |
| Market Cap (mil) | 619.92 |
| Beta | 1.53 |
| Outstanding shares (mil) | 6.16 |
| Enterprise Value (mil) | 827.98 |
| Market risk premium | 5.98% |
| Cost of Equity | 8.64% |
| Cost of Debt | 4.60% |
| WACC | 7.51% |